{"meta":{"query_hash":"cc52eefaa0b3","filters":{"venue":"Trials in Vaccinology"},"cohort_total":1,"direct_labels_cover":0,"predictions_cover":1,"exported":1,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/cc52eefaa0b3","api":"https://metacan.xera.ac/api/v1/cohort?venue=Trials+in+Vaccinology"},"results":[{"id":"W2067751168","doi":"10.1016/j.trivac.2013.12.001","title":"HIV-1 Gag-specific exosome-targeted T cell-based vaccine stimulates effector CTL responses leading to therapeutic and long-term immunity against Gag/HLA-A2-expressing B16 melanoma in transgenic HLA-A2 mice","year":2014,"lang":"en","type":"article","venue":"Trials in Vaccinology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"Canadian Institutes of Health Research","keywords":"CTL*; Virology; Cytotoxic T cell; CD8; Biology; Immunology; Group-specific antigen; Epitope; Cellular immunity; Immunity; Immune system; Antigen; Virus; In vitro","score_opus":0.0390011234271553,"score_gpt":0.30025170287960734,"score_spread":0.26125057945245206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067751168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973131,0.00039071968,0.0011672986,0.00007405698,0.000034498767,0.000041296902,0.00020522122,0.00006767394,0.0007061137],"genre_scores_gemma":[0.99517375,0.00038324954,0.0014769565,0.00007121598,0.000020039059,0.000054896525,0.0003992023,0.000018333556,0.0024023033],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982506,0.000025707886,0.000021353295,0.00004181498,0.000031708238,0.000054422715],"domain_scores_gemma":[0.99988365,0.000018457482,0.00002954624,0.000014538808,0.000008231915,0.000045537858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015150539,0.00058647967,0.00032328017,0.00019600333,0.000092056194,0.00023177701,0.00015037486,0.00034164745,0.0009170639],"category_scores_gemma":[0.00009462102,0.00016239741,0.00028770725,0.00008551302,0.00019391967,0.00028049777,0.00015490525,0.0013670739,0.00027366687],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002479885,0.00019813197,0.00010377795,0.000033895056,0.0000051678785,0.000025491345,0.000015083014,0.000076479766,0.9983333,0.00004988027,0.000033559,0.0008773149],"study_design_scores_gemma":[0.00010058013,0.002382711,0.0021369173,0.000009991298,0.000029226248,0.0002048288,0.000024917606,0.0014074866,0.9925982,0.000053865475,0.0010464665,0.0000048692527],"about_ca_topic_score_codex":0.00016581191,"about_ca_topic_score_gemma":0.0002488863,"teacher_disagreement_score":0.0009170639,"about_ca_system_score_codex":0.00014677756,"about_ca_system_score_gemma":0.00016711981,"threshold_uncertainty_score":0.0030679107},"labels":[],"label_agreement":null}]}